Cargando…

Immunotherapy and associated immune-related adverse events at a large UK centre: a mixed methods study

BACKGROUND: The development and rapid uptake of immune checkpoint inhibitors (CPI) has changed the outlook for patients with cancer. However, CPIs have different adverse event (AE) profiles to other systemic therapies, and prompt AE management is essential to assure optimal outcomes. In order to und...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jamieson, Liz, Forster, Martin D., Zaki, Kam, Mithra, Sanjena, Alli, Heena, O’Connor, Anne, Patel, Apini, Wong, Ian C. K., Chambers, Pinkie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416581/ https://www.ncbi.nlm.nih.gov/pubmed/32778064 http://dx.doi.org/10.1186/s12885-020-07215-3

Ejemplares similares

Patient factors and their impact on neutropenic events: a systematic review and meta-analysis
por: Chambers, Pinkie, et al.
Publicado: (2019)

Case-mix & patients' reports of outcome in Independent Sector Treatment Centres: Comparison with NHS providers
por: Browne, John, et al.
Publicado: (2008)

Gastrointestinal adverse events of immunotherapy
por: Cappello, Giovanni, et al.
Publicado: (2021)

Evidence to guide the optimal timing for pre‐chemotherapy blood tests for early breast, colorectal cancer and diffuse large B‐cell lymphoma
por: Chambers, Pinkie, et al.
Publicado: (2021)

Adverse Events of Oncologic Immunotherapy and Their Management
por: Barber, Fedricker Diane
Publicado: (2019)

Neurologic adverse events of cancer immunotherapy
por: de Brito, Marcelo Houat
Publicado: (2022)

Histamine‐2 (H(2)) antagonists can be safely removed from standard paclitaxel premedication regimens
por: Foreman, Emma, et al.
Publicado: (2022)

Rheumatological Adverse Events Following Immunotherapy for Cancer
por: Cretu, Ioana, et al.
Publicado: (2022)

The effect of adverse and positive experiences on inflammatory markers in Australian and UK children
por: Priest, Naomi, et al.
Publicado: (2022)

Understanding adverse events of immunotherapy: A mechanistic perspective
por: Burke, Kelly P., et al.
Publicado: (2020)

Immune-related adverse events and the balancing act of immunotherapy
por: Conroy, Michael, et al.
Publicado: (2022)

Emerging Management Approach for the Adverse Events of Immunotherapy of Cancer
por: Rahman, Md. Mominur, et al.
Publicado: (2022)

Cycling-related orthopaedic fractures admitted to the Major Trauma Centre in the cycling capital of the UK
por: Jamil, Omar, et al.
Publicado: (2021)

Hospital costs associated with adverse events in people with diabetes in the UK
por: Keng, Mi Jun, et al.
Publicado: (2022)

Aluminium adjuvants and adverse events in sub-cutaneous allergy immunotherapy
por: Exley, Christopher
Publicado: (2014)

Predictors of adverse outcome in the first and second waves of the COVID-19 pandemic: results from a UK centre
por: Martin, Christopher A., et al.
Publicado: (2022)

Details of SARS-CoV-2 reinfections at a major UK tertiary centre
por: Garvey, Mark I., et al.
Publicado: (2021)

Cutaneous Adverse Events to Targeted Therapies and Immunotherapies in Children: A Retrospective Study of 103 Patients from Two Tertiary Haemato-Oncology Referral Centres
por: OLLECH, Ayelet, et al.
Publicado: (2021)

The Irish National Adverse Events Study (INAES): the frequency and nature of adverse events in Irish hospitals—a retrospective record review study
por: Rafter, Natasha, et al.
Publicado: (2017)

Immune-related adverse events during anticancer immunotherapy: Pathogenesis and management
por: Stucci, Stefania, et al.
Publicado: (2017)

Efficacy and Adverse Events of Immunotherapy with Checkpoint Inhibitors in Older Patients with Cancer
por: van Holstein, Yara, et al.
Publicado: (2019)

Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy
por: Olsen, T. Anders, et al.
Publicado: (2022)

Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy
por: Albarrán-Artahona, Víctor, et al.
Publicado: (2022)

Immune-related adverse events of biological immunotherapies used in COVID-19
por: Baracaldo-Santamaría, Daniela, et al.
Publicado: (2022)

Rheumatic Immuno-related Adverse Events following Immunotherapy with Checkpoint Inhibitors: Adverse Drug Reaction, or Other?
por: Manzo, Ciro
Publicado: (2021)

Plain radiological investigations in admissions to a trauma centre ICU
por: O'Connor, K, et al.
Publicado: (2008)

Adverse Events in Total Ankle Arthroplasty, Analysis of the FDA Medical and User Facility Device Experience Database
por: Mahmoud, Karim, et al.
Publicado: (2019)

Personalising monitoring for chemotherapy patients through predicting deterioration in renal and hepatic function
por: Chambers, Pinkie, et al.
Publicado: (2023)

Adverse stroke outcomes amongst UK ethnic minorities: a multi-centre registry-based cohort study of acute stroke
por: Fluck, David, et al.
Publicado: (2023)

The Role of Social Media for Identifying Adverse Drug Events Data in Pharmacovigilance: Protocol for a Scoping Review
por: Golder, Su, et al.
Publicado: (2023)

UK Centre for Bioscience, Higher Education Academy
por: Adams, David J.
Publicado: (2010)

A multi-centre qualitative study exploring the experiences of UK South Asian and White Diabetic Patients referred for renal care
por: Wilkinson, Emma, et al.
Publicado: (2012)

Diabetic Ketoacidosis: An Adverse Reaction to Immunotherapy
por: Keerty, Dinesh, et al.
Publicado: (2020)

Safety and predictors of adverse events during oral immunotherapy with raw egg white
por: Vazquez-Ortiz, M, et al.
Publicado: (2013)

Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy
por: Jing, Ying, et al.
Publicado: (2020)

Immunotherapy-Associated Pancreatic Adverse Events: Current Understanding of Their Mechanism, Diagnosis, and Management
por: Liu, Ya, et al.
Publicado: (2021)

Understanding adverse events related to perioperative immunotherapy: A primer for thoracic surgeons
por: Jones, David R.
Publicado: (2021)

T follicular helper cells: linking cancer immunotherapy and immune-related adverse events
por: Baumjohann, Dirk, et al.
Publicado: (2021)

The Price of Success: Immune-Related Adverse Events from Immunotherapy in Lung Cancer
por: Coschi, Courtney H., et al.
Publicado: (2021)

Modeling Diagnostic Strategies to Manage Toxic Adverse Events following Cancer Immunotherapy
por: van Delft, Frederik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g0fdhmae0vso53f5rm5kqtep3b